427 related articles for article (PubMed ID: 29030347)
1. Extracellular Matrix Proteomics Reveals Interplay of Aggrecan and Aggrecanases in Vascular Remodeling of Stented Coronary Arteries.
Suna G; Wojakowski W; Lynch M; Barallobre-Barreiro J; Yin X; Mayr U; Baig F; Lu R; Fava M; Hayward R; Molenaar C; White SJ; Roleder T; Milewski KP; Gasior P; Buszman PP; Buszman P; Jahangiri M; Shanahan CM; Hill J; Mayr M
Circulation; 2018 Jan; 137(2):166-183. PubMed ID: 29030347
[TBL] [Abstract][Full Text] [Related]
2. Regulation of aggrecanases from the ADAMTS family and aggrecan neoepitope formation during in vitro chondrogenesis of human mesenchymal stem cells.
Boeuf S; Graf F; Fischer J; Moradi B; Little CB; Richter W
Eur Cell Mater; 2012 May; 23():320-32. PubMed ID: 22562232
[TBL] [Abstract][Full Text] [Related]
3. Role of ADAMTS-5 in Aortic Dilatation and Extracellular Matrix Remodeling.
Fava M; Barallobre-Barreiro J; Mayr U; Lu R; Didangelos A; Baig F; Lynch M; Catibog N; Joshi A; Barwari T; Yin X; Jahangiri M; Mayr M
Arterioscler Thromb Vasc Biol; 2018 Jul; 38(7):1537-1548. PubMed ID: 29622560
[TBL] [Abstract][Full Text] [Related]
4. Neointimal tissue characterization after implantation of drug-eluting stents by optical coherence tomography: quantitative analysis of optical density.
Nishino S; Sakuma M; Kanaya T; Nasuno T; Tokura M; Toyoda S; Abe S; Nakamura D; Tanaka K; Attizzani GF; Bezerra HG; Costa MA; Inoue T
Int J Cardiovasc Imaging; 2019 Nov; 35(11):1971-1978. PubMed ID: 31218524
[TBL] [Abstract][Full Text] [Related]
5. Comparison between catheter-based delivery of paclitaxel after bare-metal stenting and drug-eluting stents in coronary artery disease patients at high risk for in-stent restenosis.
El-Mokadem M; El-Ramly M; Hassan A; Boshra H; AbdelWahab A
Cardiovasc Revasc Med; 2017 Dec; 18(8):596-600. PubMed ID: 28625402
[TBL] [Abstract][Full Text] [Related]
6. Neointima and neoatherosclerotic characteristics in bare metal and first- and second-generation drug-eluting stents in patients admitted with cardiovascular events attributed to stent failure: an optical coherence tomography study.
Stettler R; Dijkstra J; Räber L; Torii R; Zhang YJ; Karanasos A; Lui S; Crake T; Hamshere S; Garcia-Garcia HM; Tenekecioglu E; Ozkor M; Windecker S; Serruys PW; Regar E; Mathur A; Bourantas CV
EuroIntervention; 2018 Feb; 13(15):e1831-e1840. PubMed ID: 28606888
[TBL] [Abstract][Full Text] [Related]
7. The Role of Vascular Imaging in Guiding Routine Percutaneous Coronary Interventions: A Meta-Analysis of Bare Metal Stent and Drug-Eluting Stent Trials.
Alsidawi S; Effat M; Rahman S; Abdallah M; Leesar M
Cardiovasc Ther; 2015 Dec; 33(6):360-6. PubMed ID: 26363283
[TBL] [Abstract][Full Text] [Related]
8. Endothelial Recovery in Bare Metal Stents and Drug-Eluting Stents on a Single-Cell Level.
Cornelissen A; Guo L; Fernandez R; Kelly MC; Janifer C; Kuntz S; Sakamoto A; Jinnouchi H; Sato Y; Paek KH; Kolodgie FD; Romero ME; Surve D; Virmani R; Finn AV
Arterioscler Thromb Vasc Biol; 2021 Aug; 41(8):2277-2292. PubMed ID: 34162228
[TBL] [Abstract][Full Text] [Related]
9. Intra-stent tissue evaluation within bare metal and drug-eluting stents > 3 years since implantation in patients with mild to moderate neointimal proliferation using optical coherence tomography and virtual histology intravascular ultrasound.
Kitabata H; Loh JP; Pendyala LK; Omar A; Ota H; Minha S; Magalhaes MA; Torguson R; Chen F; Satler LF; Pichard AD; Waksman R
Cardiovasc Revasc Med; 2014 Apr; 15(3):149-55. PubMed ID: 24767313
[TBL] [Abstract][Full Text] [Related]
10. The wound healing response after implantation of a drug-eluting stent is impaired persistently in the long term.
Nasuno T; Tokura M; Kageyama M; Toyoda S; Sakuma M; Komatsu T; Taguchi I; Abe S; Inoue T
Heart Vessels; 2016 Jun; 31(6):985-9. PubMed ID: 25939630
[TBL] [Abstract][Full Text] [Related]
11. Edge vascular response after percutaneous coronary intervention: an intracoronary ultrasound and optical coherence tomography appraisal: from radioactive platforms to first- and second-generation drug-eluting stents and bioresorbable scaffolds.
Gogas BD; Garcia-Garcia HM; Onuma Y; Muramatsu T; Farooq V; Bourantas CV; Serruys PW
JACC Cardiovasc Interv; 2013 Mar; 6(3):211-21. PubMed ID: 23517830
[TBL] [Abstract][Full Text] [Related]
12. Neointimal tissue component assessed by tissue characterization with 40 MHz intravascular ultrasound imaging: comparison of drug-eluting stents and bare-metal stents.
Tsujita K; Takaoka N; Kaikita K; Hokimoto S; Horio E; Sato K; Mizobe M; Nakayama N; Kojima S; Tayama S; Sugiyama S; Nakamura S; Ogawa H
Catheter Cardiovasc Interv; 2013 Dec; 82(7):1068-74. PubMed ID: 23460385
[TBL] [Abstract][Full Text] [Related]
13. Bioabsorbable Drug-Eluting Stent Versus Bare Metal Stent in Iliac Artery Evaluated by Optical Coherence Tomography: An In Vivo Study in Porcine.
Zhao Y; Chen Z; Zhang WW; Wang S; Yang Y; Yang L
Vasc Endovascular Surg; 2018 Oct; 52(7):512-519. PubMed ID: 30012078
[TBL] [Abstract][Full Text] [Related]
14. Comparison of neointimal coverage between durable-polymer everolimus-eluting stents and bioresorbable-polymer everolimus-eluting stents 1 year after implantation using high-resolution coronary angioscopy.
Nojima Y; Adachi H; Ihara M; Kurimoto T; Okayama K; Sakata Y; Nanto S
Catheter Cardiovasc Interv; 2019 Aug; 94(2):204-209. PubMed ID: 30737973
[TBL] [Abstract][Full Text] [Related]
15. Abnormal vasomotor function of porcine coronary arteries distal to sirolimus-eluting stents.
Li J; Jabara R; Pendyala L; Otsuka Y; Shinke T; Hou D; Robinson K; Chronos N
JACC Cardiovasc Interv; 2008 Jun; 1(3):279-85. PubMed ID: 19463313
[TBL] [Abstract][Full Text] [Related]
16. Preclinical randomised safety, efficacy and physiologic study of the silicon dioxide inert-coated Axetis and bare metal stent: short-, mid- and long-term outcome.
Pavo N; Syeda B; Bernhart A; Szentirmai E; Hemetsberger R; Samaha E; Plass C; Zlabinger K; Pavo IJ; Petrasi Z; Petnehazy Ö; Hoerstrup SP; Maurer G; Gyöngyösi M
EuroIntervention; 2015 Aug; 11(4):433-41. PubMed ID: 24769439
[TBL] [Abstract][Full Text] [Related]
17. Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplasia studY).
Valgimigli M; Tebaldi M; Borghesi M; Vranckx P; Campo G; Tumscitz C; Cangiano E; Minarelli M; Scalone A; Cavazza C; Marchesini J; Parrinello G;
JACC Cardiovasc Interv; 2014 Jan; 7(1):20-8. PubMed ID: 24332420
[TBL] [Abstract][Full Text] [Related]
18. Aggrecanases and aggrecanase-generated fragments in the human intervertebral disc at early and advanced stages of disc degeneration.
Patel KP; Sandy JD; Akeda K; Miyamoto K; Chujo T; An HS; Masuda K
Spine (Phila Pa 1976); 2007 Nov; 32(23):2596-603. PubMed ID: 17978660
[TBL] [Abstract][Full Text] [Related]
19. Biological effect on drug distribution and vascular healing via paclitaxel-coated balloon technology in drug eluting stent restenosis swine model.
Li Y; Tellez A; Rousselle SD; Dillon KN; Garza JA; Barry C; Granada JF
Catheter Cardiovasc Interv; 2016 Jul; 88(1):89-98. PubMed ID: 26613810
[TBL] [Abstract][Full Text] [Related]
20. Very early tissue coverage after drug-eluting stent implantation: an optical coherence tomography study.
Takahara M; Kitahara H; Nishi T; Miura K; Miyayama T; Sugimoto K; Nakayama T; Fujimoto Y; Kobayashi Y
Int J Cardiovasc Imaging; 2017 Jan; 33(1):25-30. PubMed ID: 27601229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
